BHRT Side Effects: Common Reactions, Serious Risks and When to Call
The short answer
The most common side effects of bioidentical hormone therapy are breast tenderness, spotting, bloating, headaches and, with progesterone, drowsiness. They often settle within the first few months or with a dose change. Serious risks such as blood clots depend on route: oral estrogen raised clot risk (odds ratio 1.58) in large UK data, while estrogen through the skin did not.
What are the most common BHRT side effects?
Bioidentical hormone replacement therapy (BHRT) uses estradiol and progesterone with the same structure as your own hormones. That structural match does not make side effects disappear: your tissues respond to estradiol and progesterone the same way whether they come from a patch, a pill, a compounded cream or your ovaries. Most early side effects reflect hormone levels that are a bit higher than your body is used to, or a dose that needs fine-tuning.
From estrogen
- Breast tenderness or swelling, the most common early complaint
- Bloating or fluid retention
- Headaches, especially if you were prone to hormonal headaches
- Nausea, more often with oral forms
- Skin irritation at patch or cream sites
- Vaginal discharge as tissue becomes better estrogenized
From progesterone
- Drowsiness or grogginess, which is why oral progesterone is usually taken at bedtime
- Mood changes, low mood or irritability in some women
- Bloating and breast tenderness
- Dizziness, mainly with oral doses
Bleeding
If you have a uterus, irregular spotting is common in the first months of combined therapy, especially when you start within a year or two of your last period. Sequential regimens cause a planned monthly bleed. Bleeding that is heavy, persists beyond the first few months, or starts after a stretch of none needs evaluation to rule out a problem with the uterine lining.
From testosterone, if prescribed
Acne, increased facial or body hair, scalp hair thinning and, at high doses, voice deepening or clitoral enlargement, which may not reverse. ACOG notes that the long-term effects of testosterone on heart disease and breast cancer risk in women are unknown (ACOG 2023).
How long do the side effects last?
Many early side effects ease within about 3 months as your body adjusts. Clinicians often schedule a check-in around then for that reason. If side effects are still bothersome, common fixes include:
| Side effect | Common adjustments a clinician may consider |
|---|---|
| Breast tenderness | Lower the estrogen dose; check for other causes |
| Headache or nausea on pills | Switch to a patch or gel for steadier levels |
| Drowsiness from progesterone | Take it at bedtime; change dose or regimen |
| Low mood on progesterone | Change dose, schedule or type of progestogen |
| Ongoing spotting | Review regimen; evaluate the uterine lining if it persists |
| Skin irritation | Rotate sites; change product |
For the flip side (when benefits typically show up), see how long BHRT takes to work.
Does BHRT cause weight gain or hair loss?
Randomized trials have not shown that estrogen therapy causes weight gain; early bloating and fluid retention can make the scale tick up for a few weeks. The shift toward more belly fat in midlife happens with or without hormones (see menopause weight gain). Hair is similar: thinning is common around menopause for many reasons, including thyroid problems and low iron. Estrogen and progesterone are not typical causes, but testosterone or high-androgen regimens can thin scalp hair in women who are prone to it.
What are the serious risks of BHRT?
Serious risks are uncommon for most healthy women in their 40s and 50s, but they are real, and "bioidentical" does not exempt anyone from them. The Menopause Society notes that risks differ by type, dose, duration, route, timing of initiation and whether a progestogen is used (Menopause Society 2022).
- Blood clots. In UK records of more than 80,000 women with clots, oral HRT was linked to higher risk (adjusted odds ratio 1.58), while transdermal estrogen was not linked to increased risk. Oral estradiol carried less risk than conjugated equine estrogens (Vinogradova 2019).
- Stroke. Oral estrogen slightly raises stroke risk, and the absolute risk climbs with age.
- Breast cancer. A worldwide analysis found all types of systemic HRT were linked to some excess breast cancer risk that rose with duration, more with estrogen plus progestogen than estrogen alone; vaginal estrogen was not (Collaborative Group 2019). In long-term Women's Health Initiative follow-up, estrogen alone after hysterectomy was associated with lower breast cancer incidence (Chlebowski 2020).
- Endometrial cancer. Estrogen without enough progestogen in a woman with a uterus raises the risk of endometrial hyperplasia and cancer. Oral micronized progesterone is the well-studied bioidentical option for protection. Progesterone absorbed from skin creams reaches low, variable blood levels, and whether that reliably protects the lining has long been debated (Stanczyk 2005), so bleeding on any regimen should be reported.
- Gallbladder disease, mainly with oral estrogen.
- Heart disease. Starting HRT more than 10 years after menopause or after 60 carries more risk; in younger, recently menopausal women, the Women's Health Initiative found low absolute risks (Manson 2013).
By the numbers
Blood clot risk depends on the route
Are compounded bioidentical hormones riskier?
They aren't known to be safer, and they come with a few risks of their own. Compounded products are not FDA-approved, so their strength can vary between batches and pharmacies, and they lack the standard patient labeling that lists risks. There is also no requirement to report adverse events, which means side effect data are thin (ACOG 2023). Pellets add the risk of hormone levels that stay high for months and can't be reversed by removing the pellet; see hormone pellet side effects.
Who should not use BHRT?
When should you call a doctor?
Get urgent care for swelling, pain or warmth in one leg; chest pain or sudden shortness of breath; a sudden severe headache; changes in vision or speech; or weakness or numbness on one side of the body.
Contact your clinician soon for heavy or prolonged bleeding, new bleeding after months without it, a breast lump, yellowing skin or eyes, or a low mood that doesn't lift.
Do the benefits outweigh the risks?
For women under 60 or within 10 years of menopause who have no contraindications, The Menopause Society considers the benefit-risk balance favorable for treating bothersome hot flashes and preventing bone loss (Menopause Society 2022). Choosing transdermal estrogen when clot risk is a concern, using an appropriate progestogen if you have a uterus, and reviewing the plan yearly all help keep risks low. Our hormone replacement therapy guide walks through that decision.
If you're considering treatment, Amie's licensed clinicians can review your history online and, if appropriate, prescribe Amie HRT+, a compounded estradiol and progesterone cream. It is not FDA-approved. The clinician will tell you if an FDA-approved product or in-person care is a better fit, and you can reach the care team if side effects come up.
The bottom line
Common questions
How long do BHRT side effects last?
Many early side effects, such as breast tenderness, bloating and irregular spotting, ease within about 3 months. If they persist or are hard to live with, a dose, timing or route change often helps. Bleeding that continues beyond the first months or starts later should be checked.
Do bioidentical hormones cause weight gain?
Clinical trials have not shown that hormone therapy causes weight gain. Some women notice fluid retention or bloating at first. Midlife weight and fat changes happen with or without hormones.
Are bioidentical hormones safer than synthetic ones?
Not in general. Transdermal estradiol and micronized progesterone have some evidence of lower clot and breast risk than older oral regimens, but the same core estrogen risks apply, and compounded products have the least safety data.
What side effects mean I should call a doctor right away?
Seek urgent care for leg swelling or pain, chest pain, sudden shortness of breath, sudden severe headache, vision or speech changes, or weakness on one side. Contact your clinician promptly about heavy or persistent bleeding, a breast lump, or yellowing skin.
Sources
- The 2022 hormone therapy position statement of The North American Menopause Society. Menopause 2022
- Vinogradova Y et al. HRT and risk of venous thromboembolism. BMJ 2019
- Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 2019
- Chlebowski RT et al. Hormone therapy and breast cancer in long-term WHI follow-up. JAMA 2020
- Manson JE et al. Hormone therapy and health outcomes in the Women's Health Initiative trials. JAMA 2013
- ACOG Clinical Consensus No. 6: Compounded Bioidentical Menopausal Hormone Therapy (2023)
- Stanczyk FZ. Percutaneous administration of progesterone: blood levels and endometrial protection. Menopause 2005
Amie prescribes in all 50 states. Find online hrt in your state.